To save money, almost 8% of U.S. adults did not take their medication as prescribed, according to National Center for Health Statistics report.
To save money, almost 8% of U.S. adults did not take their medication as prescribed, according to a National Center for Health Statistics report.
Adults aged 18 to 64 years (8.5%) were nearly twice as likely as adults aged 65 and older (4.4%) to not have taken medication as prescribed to save money.
Strategies most commonly used also differed in relation to income and insurance status.
“Lack of health insurance coverage and poverty are recognized risk factors for not taking medication as prescribed due to cost,” according to lead author of the report Robin A. Cohen, PhD. “This cost-saving strategy may result in poorer health status and increased emergency room use and hospitalizations, compared with adults who follow their recommended pharmacotherapy.”
Among U.S. adults aged 18 to 64, strategies for reducing prescription drug costs were more commonly practiced by those who were uninsured than those who had public or private insurance coverage.
Among adults aged 65 and over, those living with incomes in the 139% to 400% FPL range were more likely than adults living in lower or higher income thresholds to have asked their provider for a lower cost prescription to save money, according to the report.
“A percentage of US adults don’t take their medication as prescribed because of its costs and the use of strategies such as asking a doctor for a lower cost medication or not taking medication as prescribed,” Cohen said. “These factors differ in relation to age, income, or insurance status.”
Data from the 2013 National Health Interview Survey (NHIS) were used for this analysis.
The NHIS collects information about the health and healthcare of the civilian noninstitutionalized population of the United States. Questions about strategies to reduce prescription drug costs were introduced to the survey instrument in 2011. In 2013, these questions were asked of more than 34,000 adults aged 18 years and over.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
New PTSD Treatment Shows Promise with Brexpiprazole, Sertraline Combination
December 24th 2024Currently, the only medications approved by the FDA for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. However, these medications don’t work for everyone.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
How the Contact Center Can Be a Driver of VBC Success
December 23rd 2024Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for conveying information to patients and plan members. Today, however, AI-enabled contact centers can be drivers of value, especially in a value-based care environment.
Read More